SVB Leerink Downgrades ChemoCentryx (CCXI) to Market Perform

August 5, 2022 6:42 AM EDT
Get Alerts CCXI Hot Sheet
Price: $51.99 --0%

Rating Summary:
    4 Buy, 10 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 8 | Down: 10 | New: 31
Join SI Premium – FREE

SVB Leerink analyst Joseph Schwartz downgraded ChemoCentryx (NASDAQ: CCXI) from Outperform to Market Perform with a price target of $52.00 (from $64.00).

For an analyst ratings summary and ratings history on ChemoCentryx click here. For more ratings news on ChemoCentryx click here.

Shares of ChemoCentryx closed at $50.43 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades